The EATC4Children has a breadth and depth of experience across the entire clinical translational pathway that is of value to our industrial and academic partners to deliver on life-changing early phase clinical trials. The diagram below details the experience the EATC4Children has across the disease areas we focus on.
We not only work with industry partners to design and deliver novel clinical trials for children, but we are also involved in investigator-led clinical trials which have industry funding. Some of our investigator-led trial funding partners include Merck, Novartis and Pfizer.
Through other initiatives, like the CLUSTER Consortium, we also engage with a range of industry partners like SOBI, UCB, Pfizer, GSK and AbbVie.
---------------------
If you are looking to collaborate with the EATC4Children, please contact us: eatc@liverpool.ac.uk
Requests for information will receive a response within 14 working days. If a query needs a response more quickly than 14 days, please let us know in the request and we will do our best to accommodate this.
Back to: Experimental Arthritis Treatment Centre for Children